Literature DB >> 17416407

Achieving and maintaining asthma control in an urban pediatric disease management program: the Breathmobile Program.

Craig A Jones1, Loran T Clement, Tricia Morphew, Kenny Yat Choi Kwong, Jean Hanley-Lopez, Francene Lifson, Lawrence Opas, Jeffrey J Guterman.   

Abstract

BACKGROUND: National guidelines suggest that, with appropriate care, most patients can control their asthma. The probabilities of children achieving and maintaining control with ongoing care are unknown.
OBJECTIVE: We sought to evaluate the degree to which children in a lower socioeconomic urban setting achieve and maintain control of asthma with regular participation in a disease management program that provides guideline-based care.
METHODS: Interdisciplinary teams of asthma specialists use mobile clinics to offer ongoing care at schools and county clinics. A guideline-derived construct of asthma control is recorded at each visit.
RESULTS: Two thousand one hundred eighty-five enrollees were eligible to evaluate the time to first achieve control, and 1591 patients were eligible to evaluate subsequent control maintenance. Depending on severity, 70% to 87% of patients with persistent asthma achieved control by visit 3, and 89% to 98% achieved control by visit 6. Subsequent control maintenance was highly variable. Thirty-nine percent of patients displayed well-controlled asthma (control at >90% of subsequent visits), whereas 13% displayed difficult-to-control asthma (<50% of subsequent visits). Patients from each baseline severity category were found in each group. Maintenance of control was influenced by physician-estimated compliance with the treatment plan, baseline severity, and the interval between clinic visits.
CONCLUSIONS: Many children can achieve asthma control with regular visit intervals and guideline-based care; however, long-term control can be highly variable among patients in all severity categories. CLINICAL IMPLICATIONS: These findings highlight the need and feasibility for systematically tracking each patient's clinical response to individualize therapy and guide the use of population management strategies.

Entities:  

Mesh:

Year:  2007        PMID: 17416407     DOI: 10.1016/j.jaci.2007.02.031

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  14 in total

1.  Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial.

Authors:  Stanley J Szefler; Herman Mitchell; Christine A Sorkness; Peter J Gergen; George T O'Connor; Wayne J Morgan; Meyer Kattan; Jacqueline A Pongracic; Stephen J Teach; Gordon R Bloomberg; Peyton A Eggleston; Rebecca S Gruchalla; Carolyn M Kercsmar; Andrew H Liu; Jeremy J Wildfire; Matthew D Curry; William W Busse
Journal:  Lancet       Date:  2008-09-20       Impact factor: 79.321

2.  Development and validation of the Composite Asthma Severity Index--an outcome measure for use in children and adolescents.

Authors:  Jeremy J Wildfire; Peter J Gergen; Christine A Sorkness; Herman E Mitchell; Agustin Calatroni; Meyer Kattan; Stanley J Szefler; Stephen J Teach; Gordon R Bloomberg; Robert A Wood; Andrew H Liu; Jacqueline A Pongracic; James F Chmiel; Kathleen Conroy; Yadira Rivera-Sanchez; William W Busse; Wayne J Morgan
Journal:  J Allergy Clin Immunol       Date:  2012-01-12       Impact factor: 10.793

Review 3.  Leveraging Partnerships: Families, Schools, and Providers Working Together to Improve Asthma Management.

Authors:  Melanie Gleason; Lisa Cicutto; Christy Haas-Howard; Bridget M Raleigh; Stanley J Szefler
Journal:  Curr Allergy Asthma Rep       Date:  2016-10       Impact factor: 4.806

4.  Asthma in Head Start children: effects of the Breathmobile program and family communication on asthma outcomes.

Authors:  Michelle N Eakin; Cynthia S Rand; Andrew Bilderback; Mary E Bollinger; Arlene Butz; Veni Kandasamy; Kristin A Riekert
Journal:  J Allergy Clin Immunol       Date:  2011-11-21       Impact factor: 10.793

5.  Adherence to inhaled corticosteroids: an ancillary study of the Childhood Asthma Management Program clinical trial.

Authors:  Jerry A Krishnan; Bruce G Bender; Frederick S Wamboldt; Stanley J Szefler; N Franklin Adkinson; Robert S Zeiger; Robert A Wise; Andrew L Bilderback; Cynthia S Rand
Journal:  J Allergy Clin Immunol       Date:  2011-11-21       Impact factor: 10.793

6.  Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma study.

Authors:  Robert C Strunk; Leonard B Bacharier; Brenda R Phillips; Stanley J Szefler; Robert S Zeiger; Vernon M Chinchilli; Fernando D Martinez; Robert F Lemanske; Lynn M Taussig; David T Mauger; Wayne J Morgan; Christine A Sorkness; Ian M Paul; Theresa Guilbert; Marzena Krawiec; Ronina Covar; Gary Larsen
Journal:  J Allergy Clin Immunol       Date:  2008-10-25       Impact factor: 10.793

Review 7.  Well-child care clinical practice redesign for young children: a systematic review of strategies and tools.

Authors:  Tumaini R Coker; Annika Windon; Candice Moreno; Mark A Schuster; Paul J Chung
Journal:  Pediatrics       Date:  2013-03       Impact factor: 7.124

8.  Long-term maintenance of pediatric asthma: focus on budesonide/formoterol inhalation aerosol.

Authors:  Peter N Huynh; Lyne G Scott; Kenny Yc Kwong
Journal:  Ther Clin Risk Manag       Date:  2010-03-03       Impact factor: 2.423

9.  Socioeconomic, family, and pediatric practice factors that affect level of asthma control.

Authors:  Gordon R Bloomberg; Christina Banister; Randall Sterkel; Jay Epstein; Julie Bruns; Lisa Swerczek; Suzanne Wells; Yan Yan; Jane M Garbutt
Journal:  Pediatrics       Date:  2009-03       Impact factor: 7.124

10.  Asthma in a primary health care center serving a poor population: a descriptive and interventional study.

Authors:  Eloisa Malbrán; Graciela Laura Rey; Alejandro Malbrán
Journal:  World Allergy Organ J       Date:  2008-12       Impact factor: 4.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.